BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

45 related articles for article (PubMed ID: 27572250)

  • 1. Prevalence and molecular characterization of colistin resistance in Pseudomonas aeruginosa isolates: insights from a study in Ardabil hospitals.
    Jafari-Ramedani S; Nazari M; Arzanlou M; Peeri-Dogaheh H; Sahebkar A; Khademi F
    BMC Microbiol; 2024 May; 24(1):152. PubMed ID: 38702660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of an efflux pump inhibitor to determine the prevalence of efflux pump-mediated fluoroquinolone resistance and multidrug resistance in Pseudomonas aeruginosa.
    Kriengkauykiat J; Porter E; Lomovskaya O; Wong-Beringer A
    Antimicrob Agents Chemother; 2005 Feb; 49(2):565-70. PubMed ID: 15673734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efflux pump effects on
    Valıyeva G; Durupınar B; Coban AY
    J Chemother; 2023 Nov; 35(7):601-609. PubMed ID: 36718107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of genes related to the efflux pump and porin in multidrug-resistant Escherichia coli strains isolated from patients with COVID-19 after secondary infection.
    Ganjo AR; Balaky STJ; Mawlood AH; Smail SB; Shabila NP
    BMC Microbiol; 2024 Apr; 24(1):122. PubMed ID: 38600509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efflux pump effects on levofloxacin resistance in
    Teng T; Chen S; Huo F; Jia J; Zhao L; Jiang G; Wang F; Chu N; Huang H
    Antimicrob Agents Chemother; 2024 May; 68(5):e0134823. PubMed ID: 38572960
    [No Abstract]   [Full Text] [Related]  

  • 6. Antibacterial and Anti-Efflux Activities of Cinnamon Essential Oil against Pan and Extensive Drug-Resistant
    Abdelatti MAI; Abd El-Aziz NK; El-Naenaeey EYM; Ammar AM; Alharbi NK; Alharthi A; Zakai SA; Abdelkhalek A
    Antibiotics (Basel); 2023 Oct; 12(10):. PubMed ID: 37887215
    [No Abstract]   [Full Text] [Related]  

  • 7. Study on the Mechanism of Levofloxacin Combined with Imipenem Against Pseudomonas aeruginosa.
    Lu Q; Yang Q
    Appl Biochem Biotechnol; 2024 Feb; 196(2):690-700. PubMed ID: 37178250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in the expression of mexB, mexY, and oprD in clinical Pseudomonas aeruginosa isolates.
    Matsumoto Y; Yamasaki S; Hayama K; Iino R; Noji H; Yamaguchi A; Nishino K
    Proc Jpn Acad Ser B Phys Biol Sci; 2024; 100(1):57-67. PubMed ID: 38199247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biosensors for Inducers of Transient Antibiotic Resistance.
    Laborda P; Alcalde-Rico M; Gil-Gil T; Martínez JL; Blanco P
    Methods Mol Biol; 2024; 2721():103-121. PubMed ID: 37819518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efflux pump inhibitor, phenylalanine-arginine beta-naphthylamide analog potentiates the activity of 5-O-mycaminosyltylonolide for multi-drug resistant Pseudomonas aeruginosa.
    Kimishima A; Honsho M; Terai J; Wasuwanich P; Honma S; Matsui H; Hanaki H; Asami Y
    J Antibiot (Tokyo); 2024 May; 77(5):331-333. PubMed ID: 38467778
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Response of
    Augustyniak A; Cendrowski K; Grygorcewicz B; Jabłońska J; Nawrotek P; Trukawka M; Mijowska E; Popowska M
    Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33092046
    [No Abstract]   [Full Text] [Related]  

  • 12. A Novel and Quantitative Detection Assay (
    Rattanachak N; Weawsiangsang S; Baldock RA; Jaifoo T; Jongjitvimol T; Jongjitwimol J
    Methods Protoc; 2023 Oct; 6(5):. PubMed ID: 37888028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Repurposing approved drugs as potential efflux pump inhibitors in multidrug-resistant
    de Melo Guedes GM; Pereira VC; Freitas AS; Honório de Souza PR; Chacon Parra AL; Brasil JA; de Medeiros Guedes RF; Pereira de Sousa PC; Aguiar Cordeiro R; Gadelha Rocha MF; Costa Sidrim JJ; Souza Collares Maia Castelo Branco D
    Future Microbiol; 2024 Apr; ():. PubMed ID: 38629920
    [No Abstract]   [Full Text] [Related]  

  • 14. Molecular Epidemiology of Mutations in Antimicrobial Resistance Loci of Pseudomonas aeruginosa Isolates from Airways of Cystic Fibrosis Patients.
    Greipel L; Fischer S; Klockgether J; Dorda M; Mielke S; Wiehlmann L; Cramer N; Tümmler B
    Antimicrob Agents Chemother; 2016 Nov; 60(11):6726-6734. PubMed ID: 27572404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survey of various carbapenem-resistant mechanisms of
    Azimi L; Fallah F; Karimi A; Shirdoust M; Azimi T; Sedighi I; Rahbar M; Armin S
    Iran J Basic Med Sci; 2020 Nov; 23(11):1396-1400. PubMed ID: 33235696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of antimicrobial resistance, biofilm forming potential, and the presence of biofilm-related genes among clinical isolates of Pseudomonas aeruginosa.
    Kamali E; Jamali A; Ardebili A; Ezadi F; Mohebbi A
    BMC Res Notes; 2020 Jan; 13(1):27. PubMed ID: 31924268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Photodynamic antimicrobial activity of new porphyrin derivatives against methicillin resistant Staphylococcus aureus.
    Taslı H; Akbıyık A; Topaloğlu N; Alptüzün V; Parlar S
    J Microbiol; 2018 Nov; 56(11):828-837. PubMed ID: 30353469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of the Multidrug Efflux Pumps in Betalactams Resistant Pseudomonas aerugionsa Clinical Isolates Collected from Burn Patients in Iran.
    Bijari A; Azimi L; Fallah F; Ardebili A; Lari ER; Lari AR
    Infect Disord Drug Targets; 2016; 16(3):172-177. PubMed ID: 27572250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Collateral sensitivity between aminoglycosides and beta-lactam antibiotics depends on active proton pumps.
    Azimi L; Rastegar Lari A
    Microb Pathog; 2017 Nov; 112():122-125. PubMed ID: 28958949
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.